Natural killer cells and tumor immunity: 1985.
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000648:ultrastructure; D003602:Cytotoxicity, Immunologic; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive / Q000379:methods; D007376:Interleukin-2 / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology / Q000648:ultrastructure; D007797:Laminin / Q000276:immunology; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D011956:Receptors, Cell Surface / Q000502:physiology; D013601:T-Lymphocytes / Q000648:ultrastructure; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000648:ultrastructure; D014409:Tumor Necrosis Factor-alpha
D006023:Glycoproteins; D007376:Interleukin-2; D007797:Laminin; D011956:Receptors, Cell Surface; D014409:Tumor Necrosis Factor-alpha